Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., Rosenberg, S. A., & Horning, S. J. (2010). Stage I-IIA Non-Bulky Hodgkin Lymphoma. Is Further Distinction Based on Prognostic Factors Useful? The Stanford Experience.
Chicago Style CitationAdvani, Ranjana H., Richard T. Hoppe, Lauren S. Maeda, David M. Baer, Joseph Mason, Saul A. Rosenberg, i Sandra J. Horning. Stage I-IIA Non-Bulky Hodgkin Lymphoma. Is Further Distinction Based On Prognostic Factors Useful? The Stanford Experience. 2010.
Cita MLAAdvani, Ranjana H., et al. Stage I-IIA Non-Bulky Hodgkin Lymphoma. Is Further Distinction Based On Prognostic Factors Useful? The Stanford Experience. 2010.
Atenció: Aquestes cites poden no estar 100% correctes.